HCPLive Network

Evidence Discredits Aggressive UTI Testing in Young Children

 
MONDAY, Jan. 21 (HealthDay News) -- Guidelines recommending aggressive testing of young children with fevers for urinary tract infections (UTIs) should be revisited given the lack of evidence and long-term justification, according to research published online Jan. 11 in the Annals of Emergency Medicine.

Noting that the American Academy of Pediatrics' guidelines recommend aggressive diagnosis, treatment, and investigation of possible pediatric urinary tract infection in children with fever who are younger than 2 years, David H. Newman, M.D., of the Mount Sinai School of Medicine in New York City, and colleagues reviewed the literature to examine the utility and efficacy of this early identification and treatment. They focused specifically on the utility of antibiotics for reducing delayed renal complications and the utility of timely diagnosis and treatment in prevention of renal scarring.

The researchers found that, although two studies linked aggressive and early identification of urinary tract infection with prevention of long-term renal complications, a more substantive body of evidence did not find evidence for this link. In addition, renal scarring was found to be relatively common, but there was no evidence suggesting that scarring has long-term sequelae.

"Pediatric urinary tract infection in well children does not appear to result in currently identifiable long-term clinical sequelae, and antimicrobial treatment appears unable to affect either intermediary markers such as renal scarring or long-term outcome," the authors write. "Aggressive testing may be more harmful than helpful. An initial observational approach to well children with fever seems reasonable."
 

Abstract
Full Text (subscription or payment may be required)


Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Various nonantibiotic prophylaxis options are available, some of which may be beneficial for adults with recurrent urinary tract infections, according to a review and meta-analysis published in the December issue of The Journal of Urology.
For patients with sinusitis or urinary tract infection, follow-up is similar following office visits or e-visits, but antibiotics are more likely to be prescribed and preventive care is less likely with e-visits, according to a research letter published in the Jan. 14 issue of JAMA Internal Medicine.
U.S. Food and Drug Administration approval of Botox (onabotulinumtoxinA) has been expanded to include adults with overactive bladder who don't respond to anticholinergics.
The majority of patients with current or recent Clostridium difficile infection receive unnecessary antimicrobials, with 26 percent receiving only unnecessary antimicrobials, according to research published in the February issue of Infection Control and Hospital Epidemiology.
Researchers at Tufts University have published a timely review of the cranberry’s phytochemical composition with emphasis on urinary and cardiovascular heath.
New guidelines discussed at AAP 2012 cover assessment, diagnosis, and treatment of urinary tract infections in children up to two years of age.
An update from the American Academy of Pediatrics suggests strategies for prescribing antibiotics for bacterial upper respiratory tract infections in children.
More Reading